Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCTs031180261Completed
Open-label, single-arm trial of capecitabine and temozolomide in apudoma (NET), sponsored by Yokohama City University Hospital. Primary endpoint: Response rate. Started Oct 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCTs031180261.